Pharmacy Times

FEBRUARY 8, 2024

Ibrutinib and other Bruton tyrosine kinase inhibitors can cause the development of or worsen pre-existing hypertension.

145

145

STAT

FEBRUARY 8, 2024

Despite widespread promises of reform after the murder of George Floyd in 2020, in 2023, police killed at least 1,246 people — the most in more than a decade. This police violence is intertwined with a parallel public policy disaster: America’s abysmal mental health systems that force police officers to function as de facto mental health workers.

144

144

Fierce Pharma

FEBRUARY 8, 2024

Thursday, when senators questioned three Big Pharma CEOs about the high price of drugs in the U.S., Health, Education, Labor and Pensions (HELP) committee chairman Bernie Sanders, I-Vermont, put th | CEOs from Bristol Myers Squibb, Johnson & Johnson and Merck faced tough questions from senators on why prices for drugs in the U.S. exceed those in other countries.

139

139

STAT

FEBRUARY 8, 2024

People receiving a double dose of naloxone are no more likely to survive an opioid overdose than people receiving a standard, 4-milligram nasal spray, according to a new study. The new paper , published Thursday in the Centers for Disease Control and Prevention’s Morbidity and Mortality Weekly Report, showed no significant difference in survival rates between people who were revived using 4- and 8-milligram sprays of naloxone, commonly known by the brand name Narcan.

144

144

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Pharmacy Times

FEBRUARY 8, 2024

Investigators found high incidences of non-susceptibility with penicillin and increasing resistance to macrolides for pneumococcal diseases.

Vaccines 132

Vaccines 132

STAT

FEBRUARY 8, 2024

A critical government advisory committee charged with charting U.S. vaccination policy appears to be atrophying, jeopardizing timely decision-making on how vaccines should be used in this country. The Advisory Committee on Immunization Practices, which has in recent years been a 15-person panel, has eight vacancies — one of which dates back more than a year.

Vaccines 141

Vaccines Immunization 141

STAT

FEBRUARY 8, 2024

Three years ago, Jamie Lin, an early-career nephrologist at MD Anderson Cancer Center, made findings that could potentially help both save the kidneys of cancer patients and propel her career as a physician-scientist hoping to one day run her own lab. It was a promising start, but that’s when Lin says one of the Texas institute’s most powerful researchers interfered.

138

138

Fierce Pharma

FEBRUARY 8, 2024

With $45.8 billion in 2023 revenues, AstraZeneca has met the $45 billion-by-2023 goal CEO Pascal Soriot established in 2014 when he was fending off a takeover bid from Pfizer. | AstraZeneca has met the $45 billion-by-2023 revenue goal that CEO Pascal Soriot established in 2014. But questions have emerged for one of the company's key growth drivers.

128

128

STAT

FEBRUARY 8, 2024

The world may be getting over the idea that men are from Mars and women from Venus , but public perception still holds that testosterone is the male hormone , and estrogen, the female. That can make the following fact a little puzzling: There is more testosterone than estrogen in a premenopausal woman’s body. Testosterone levels decrease with time and reach especially low values after menopause, which can lead to loss of bone density, lower energy, and depression.

137

137

Pharmacy Times

FEBRUARY 8, 2024

This agent can prevent the depletion of heparan sulphate in the endothelial glycocalyx layer of endothelial cells, ultimately protecting against vision loss and renal failure caused by diabetes.

123

123

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

STAT

FEBRUARY 8, 2024

Has AI really solved biology? What can machines teach us about medicine? And what’s a digital twin? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. It’s our all-AI episode. First, STAT’s Casey Ross joins us to explain his reporting on how researchers and pharmaceutical firms are using the technology to find new drug targets, design therapies, and improve clinical trials.

128

128

Pharmacy Times

FEBRUARY 8, 2024

The CDC recommends RSV vaccination for all adults aged 60 years and older.

Vaccines 123

Vaccines 123

STAT

FEBRUARY 8, 2024

This week, I address pushback I received on my Novartis-MorphoSys column. But first, a preview of the expected readout from Gritstone Bio’s neoantigen cancer vaccine study. A looming test for neoantigen cancer vaccines Before the end of the quarter, Gritstone Bio will release preliminary results from a randomized, Phase 2 clinical trial investigating a personalized therapeutic cancer vaccine in microsatellite-stable colon cancer, a type of “immunologically cold” tumor that i

Vaccines 128

Vaccines FDA 128

Pharmacy Times

FEBRUARY 8, 2024

The study authors noted that further research with larger populations should be conducted to boost the reliability and generalizability of the results.

Immunization 123

Immunization 123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

FEBRUARY 8, 2024

LONDON — Medicare’s first-ever drug pricing negotiations are officially underway. But neither government officials nor drugmakers are wanting to show their cards, at least publicly. Last week, Medicare made its first offers to the makers of the 10 products subject to negotiation, though it said it would be up to the companies to discuss the proposals.

124

124

Drug Topics

FEBRUARY 8, 2024

The link between high-risk human papillomavirus infection and atherosclerotic cardiovascular disease mortality was strongest in women with obesity.

123

123

Drug Store News

FEBRUARY 8, 2024

Mary Langowski, Manmohan Mahajan and Elizabeth Burger are among the executives taking on senior leadership roles.

122

122

Fierce Healthcare

FEBRUARY 8, 2024

Enrollment in individual market plans continues to grow, with a record high of 21.3 million people signing up for plans during the most recent open enrollment period. | CEO Mark Bertolini told investors that Oscar “closed out 2023 with another strong quarter, driving financial performance for the full year.

119

119

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

pharmaphorum

FEBRUARY 8, 2024

Gilead Sciences has said it will no longer develop its CD47-targeting antibody magrolimab in blood cancers after data suggested that patients taking the drug in clinical trials were more likely to die than those in control groups.

119

119

STAT

FEBRUARY 8, 2024

WASHINGTON — Call it Sen. Bernie Sanders’ prescription drug pricing theater. The hearing, featuring Merck CEO Robert Davis, Johnson and Johnson CEO Joaquin Duato, and Bristol Myers Squibb CEO Chris Boerner, was designed to draw public interest, and in that respect, it worked. The wood-paneled hearing room in a Senate office building was standing room only, with an overflow room prepared.

118

118

pharmaphorum

FEBRUARY 8, 2024

Epidemiological studies can often throw out intriguing and sometimes erroneous correlations between a variable and a disease, but UK scientists say a finding that Alzheimer’s disease seems to be less common in Viagra users warrants further investigation.

23

23

STAT

FEBRUARY 8, 2024

By some measures, private equity investment lagged in 2023, a year marked by growing distress and high-profile downfalls among private equity-backed health care companies. Even so, three sectors still managed to see strong deal flow and prices: med spa, cardiology, and clinical trial sites, according to a new PitchBook report analyzing private equity investments in health care services in 2023.

Hospitals 116

Hospitals Insurance 116

pharmaphorum

FEBRUARY 8, 2024

Stay up to date with the latest updates in the world of clinical trials. This week's highlights include Bayer's new study on aflibercept, BioNTech's groundbreaking research, and the exciting developments from Duality Bio. Get all the important information here.

115

115

Fierce Pharma

FEBRUARY 8, 2024

Roughly an eon ago in the pharma industry (read: 20 years), Sandoz carved out a sizable generics foothold through dual mergers with Germany’s Hexal and U.S.-based Eon Labs. | Nearly 20 years after Sandoz carved out a sizable generics foothold via dual mergers with Germany’s Hexal and U.S.-based Eon Labs, the Swiss manufacturing giant is mothballing one of the latter company’s main manufacturing sites.

115

115

Drug Store News

FEBRUARY 8, 2024

The webinar highlighted how you can transform your pharmacy into a higher performing business that improves patient health and generates more revenue.

115

115

STAT

FEBRUARY 8, 2024

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and medicine.  Sign up here  to receive it in your inbox on Tuesdays and Thursdays. A road test for fresh pharma CEOs A lot can change in five years — including the leadership of the three major pharmaceutical companies that will be testifying before Sen.

Pharmaceutical Companies 114

Pharmaceutical Companies Pharmaceutical Companies Vaccines 114

Drug Store News

FEBRUARY 8, 2024

The organization noted that the 1984 law has enabled trillions of dollars in savings, but the industry is at risk.

111

111

STAT

FEBRUARY 8, 2024

Want to stay on top of the science and politics driving biotech today?  Sign up  to get our biotech newsletter in your inbox. Good morning, everyone. Damian here with the latest Senate harangue for the drug industry, green shoots in biotech sentiment, and the potential of a gene therapy eye drop.

112

112

Hospital Pharmacy Europe

FEBRUARY 8, 2024

Tiene Bauters, PharmD PhD, Pharmacy Department , Ghent University Hospital in Belgium, offers her take on what’s hot on the horizon for hospital pharmacy in 2024. We have just stepped into a new year, and it is already clear that the pharmacy landscape is set to experience significant innovations and challenges over the coming weeks and months. These will undoubtedly present great opportunities for hospital pharmacists and their teams.

Hospitals 111

Hospitals Health and Personal Care Stores Medical Records Compounding 111

pharmaphorum

FEBRUARY 8, 2024

China has become the first country in the world to approve Roche’s anti-complement C5 antibody crovalimab, the only treatment for the rare disorder paroxysmal nocturnal haemoglobinuria (PNH) that can be given by subcutaneous injection.

111

111

Pharmaceutical Technology

FEBRUARY 8, 2024

AFFINITY data has spurred RegenxBio towards a pivotal study for DMD while pivotal CAMPSIITE data has the company moving towards an FDA BLA.

FDA 111

FDA 111

pharmaphorum

FEBRUARY 8, 2024

BioNTech has taken a $200 million stake in Autolus in a private placement that will allow it to tap into the UK company’s manufacturing capacity for CAR-T therapies

110

110

Drug Store News

FEBRUARY 8, 2024

Instacart Fulfillment as a Service helps Hy-Vee increase order fulfillment, expand delivery options and optimize services for customers.

106

106